SEARCH OUR PRODUCT CATALOG

MTAP-CDKN2A Fusion FISH Probe

The MTAP-CDKN2A Fusion FISH Probe is used to confirm a fusion of the MTAP and CDKN2A genes. The fusion of the MTAP and CDKN2A genes has been associated with Mesothelioma, and Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.

** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.

Turnaround Time: 7-10 Business Days    Shipping Time: 1-2 Day Expedited Shipping

SKU Test Kits Buffer Dye Color Order Now
MTAP-CDKN2A-20-ORGR  (Standard Design) 20 (40 μL) 200 μL
MTAP-CDKN2A-20-RERE 20 (40 μL) 200 μL
MTAP-CDKN2A-20-REOR 20 (40 μL) 200 μL
MTAP-CDKN2A-20-REGO 20 (40 μL) 200 μL
MTAP-CDKN2A-20-REGR 20 (40 μL) 200 μL
MTAP-CDKN2A-20-REAQ 20 (40 μL) 200 μL
MTAP-CDKN2A-20-ORRE 20 (40 μL) 200 μL
MTAP-CDKN2A-20-OROR 20 (40 μL) 200 μL
MTAP-CDKN2A-20-ORGO 20 (40 μL) 200 μL
MTAP-CDKN2A-20-ORAQ 20 (40 μL) 200 μL
MTAP-CDKN2A-20-GORE 20 (40 μL) 200 μL
MTAP-CDKN2A-20-GOOR 20 (40 μL) 200 μL
MTAP-CDKN2A-20-GOGO 20 (40 μL) 200 μL
MTAP-CDKN2A-20-GOGR 20 (40 μL) 200 μL
MTAP-CDKN2A-20-GOAQ 20 (40 μL) 200 μL
MTAP-CDKN2A-20-GRRE 20 (40 μL) 200 μL
MTAP-CDKN2A-20-GROR 20 (40 μL) 200 μL
MTAP-CDKN2A-20-GRGO 20 (40 μL) 200 μL
MTAP-CDKN2A-20-GRGR 20 (40 μL) 200 μL
MTAP-CDKN2A-20-GRAQ 20 (40 μL) 200 μL
MTAP-CDKN2A-20-AQRE 20 (40 μL) 200 μL
MTAP-CDKN2A-20-AQOR 20 (40 μL) 200 μL
MTAP-CDKN2A-20-AQGO 20 (40 μL) 200 μL
MTAP-CDKN2A-20-AQGR 20 (40 μL) 200 μL
MTAP-CDKN2A-20-AQAQ 20 (40 μL) 200 μL

CDKN2A Gene Summary

This gene generates several transcript variants which differ in their first exons. At least three alternatively spliced variants encoding distinct proteins have been reported, two of which encode structurally related isoforms known to function as inhibitors of CDK4 kinase. The remaining transcript includes an alternate first exon located 20 Kb upstream of the remainder of the gene; this transcript contains an alternate open reading frame (ARF) that specifies a protein which is structurally unrelated to the products of the other variants. This ARF product functions as a stabilizer of the tumor suppressor protein p53 as it can interact with, and sequester, the E3 ubiquitin-protein ligase MDM2, a protein responsible for the degradation of p53. In spite of the structural and functional differences, the CDK inhibitor isoforms and the ARF product encoded by this gene, through the regulatory roles of CDK4 and p53 in cell cycle G1 progression, share a common functionality in cell cycle G1 control. This gene is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene. [provided by RefSeq, Sep 2012]

Gene Name: Cyclin Dependent Kinase Inhibitor 2A

Chromosome: CHR9: 21967750 -21994490

Locus: 9p21.3

MTAP Gene Summary

This gene encodes an enzyme that plays a major role in polyamine metabolism and is important for the salvage of both adenine and methionine. The encoded enzyme is deficient in many cancers because this gene and the tumor suppressor p16 gene are co-deleted. Multiple alternatively spliced transcript variants have been described for this gene, but their full-length natures remain unknown. [provided by RefSeq, Jul 2008]

Gene Name: Methylthioadenosine Phosphorylase

Chromosome: CHR9: 21802634 -21865969

Locus: 9p21.3

Gene Diseases

The MTAP CDKN2A Fusion has been associated with the following diseases:

Disease Name
Mesothelioma
Breast Invasive Carcinoma

FISH Probe Protocols

Protocol, Procedure, or Form Name Last Modified Download

Distinct Patterns of Acral Melanoma Based on Site and Relative Sun Exposure

Acral melanomas vary considerably in their molecular, histological, and clinical presentation. In this study, acral melanomas from dorsal, volar, and subungual-interdigital body sites were assessed using several tests, including FISH. Our TERT, CCND1, CDK4, AURKA, CDKN2A, PAK1, PTEN, NF1, and GAB2 probes were used to detect copy number variations in these genes. Genetic profiles were found to be tightly tied to UV exposure.

Distinct Patterns of Acral Melanoma Based on Site and Relative Sun Exposure

Acral melanomas vary considerably in their molecular, histological, and clinical presentation. In this study, acral melanomas from dorsal, volar, and subungual-interdigital body sites were assessed using several tests, including FISH. Our TERT, CCND1, CDK4, AURKA, CDKN2A, PAK1, PTEN, NF1, and GAB2 probes were used to detect copy number variations in these genes. Genetic profiles were found to be tightly tied to UV exposure.